Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 1,270 | reported | 13 Aug 2018 | tx 7+22,322−2,540 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Aug 2018 | SALE | Avalo Therapeutics, Inc. | 1,270 | 3.98 USD | |
| 13 Aug 2018 | EXERCISE | Avalo Therapeutics, Inc. | 1,270 | 3.20 USD | |
| 13 Aug 2018 | EXERCISE | Avalo Therapeutics, Inc. | 1,270 | 0.00 USD | deriv |
| 29 Jun 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 1,012 | 0.00 USD | deriv |
| 31 Mar 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 2,056 | 0.00 USD | deriv |
| 31 Dec 2017 | GRANT_AWARD | Avalo Therapeutics, Inc. | 1,270 | 0.00 USD | deriv |
| 17 Nov 2017 | GRANT_AWARD | Avalo Therapeutics, Inc. | 16,714 | 0.00 USD | deriv |